What You Should Know
Forus, the AI-powered network connecting physicians, retail and specialty pharmacies, commercial payers, and biopharma manufacturers, announced a $150M Series C financing round at a $3B valuation.The round triples the company’s valuation just months following its Series B round, lifting cumulative equity financing past $300M.Led by seed-stage backer Bain Capital Ventures, the insider round featured 100% reinvestment from existing institutional backers, including Thrive
Read More
Flow Neuroscience Launches FDA-Approved At-Home tDCS Treatment for Major Depressive Disorder
What You Should Know
Swedish neurotechnology company Flow Neuroscience officially launched FL-100 across the United States, introducing the first FDA-approved at-home transcranial direct current stimulation (tDCS) treatment for depression to the American market.Backed by formal premarket approval (FDA PMA P230024), the prescription-only medical device is indicated for adults (18+) with moderate to severe major depressive disorder (MDD) in the current episode who are not treatment-refractory,
Read More
Salesforce Unveils Agentic Life Sciences Suite to Turn Reactive Operations into Compliant-by-Design Intelligence
What You Should Know
Salesforce announced three major enterprise artificial intelligence additions to its life sciences portfolio: Regulated Content Management (RCM), Command Center for Life Sciences, and Life Sciences MCP (Model Context Protocol).Focuses on widespread industry inefficiencies, targeting scenarios where half of all pharmaceutical drug launches fail to meet pre-launch projections and commercial teams spend months waiting for manual Medical, Legal, and Regulatory (MLR)
Read More
PatientIQ Closes $30M to Scale EHR-Integrated Outcomes Intelligence and RWE
What You Should Know
Healthcare outcomes intelligence leader PatientIQ has raised $30M in Series C financing led by Chicago-based healthcare private equity firm Hughes & Company, with continued backing from Health Enterprise Partners and August Capital.Since completing its Series B round in 2022, PatientIQ has scaled its EHR-integrated footprint from 200 to more than 870 healthcare provider organizations, covering over 17 million patients and capturing more than 70 million patient
Read More
FDA Clears Kneu Health Apple Watch Tool for 24/7 Parkinson’s Tremor and Dyskinesia Monitoring
What You Should Know
The U.S. Food and Drug Administration (FDA) has cleared a new Apple Watch-based monitoring tool developed by Kneu Health for clinical tracking of Parkinson’s disease symptoms.Provides 24/7 continuous passive measurement of tremor alongside the platform's first-time capability to track dyskinesia—the involuntary movements often triggered as a side effect of long-term dopaminergic medications.Pairs continuous, passive smartwatch data with active, smartphone-based motor and
Read More
Ultrahuman Raises $70M to Build a Multimodal Human-Computer Interface for Health
What You Should Know
Bengaluru-based health intelligence company Ultrahuman announced a $70M financing round to evolve from a consumer wearable maker into an extensible human-computer interface (HCI) platform centered on the human body.The syndicate includes corporate heavyweights Qualcomm Ventures and Labcorp (via the Labcorp Venture Fund), alongside venture and growth investors Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital.Expands Pulsomics, an embedded opt-in
Read More
Mayo Clinic Platform Accelerate Launches Multiyear Pathway for 12 Clinical AI Startups
What You Should Know:
- Mayo Clinic Platform has launched a multiyear pathway program within its Accelerate initiative, announcing an inaugural cohort of 12 health technology companies focused on artificial intelligence across care delivery and enterprise operations.
- Since its launch in 2022, Mayo Clinic Platform Accelerate has supported over 130 portfolio companies globally, historically leaning on structured 30-week tracks.
- The new multiyear pathway expands that
Read More
Thyme Care Secures Over $125M, Launches Thyme Companies to Scale Oncology Innovation
What You Should Know
Value-based oncology navigation and management leader Thyme Care announced a Series E financing round exceeding $125M, led by Morgan Health.Strategic and institutional syndication includes major national payers and healthcare venture firms: Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.The company manages more than $7Bin annual oncology spend, with
Read More
Elucid Raises $55M to Expand Non-Invasive Cardiovascular Diagnostic Platform
What You Should Know
Boston-based cardiovascular medtech innovator Elucid closed an oversubscribed $55M Series D financing round, bringing its cumulative funding to approximately $185M.The round features participation from a new major, publicly traded medical device company—becoming Elucid’s fourth publicly traded strategic backer—alongside existing investors including IAG Capital Partners and Elevage Medical Technologies (a Patient Square Capital platform).Proceeds will accelerate the
Read More
M&A: Cureety Acquires Reimagine Care to Expand Precision Oncology Platform Across 250 Cancer Centers
What You Should Know
Paris-based precision oncology company Cureety has acquired Nashville-based Reimagine Care, uniting therapy-specific remote clinical intelligence with conversational AI patient engagement and specialized human care teams.The combined entity operates as a profitable organization serving more than 250 cancer centers and 100,000 patients across five countries, with a joint workforce of approximately 150 employees.Integrates Reimagine Care’s conversational AI platform, Remi,
Read More
